View in EDS HTML Full Text PDF Full Text

Data from French named patient program of quizartinib in relapsed/refractory acute myeloid leukemia.

Saved in:
Bibliographic Details
Title: Data from French named patient program of quizartinib in relapsed/refractory acute myeloid leukemia.
Authors: Fodil, S.1 (AUTHOR), Raffoux, E.1 (AUTHOR), Dumas, P. Y.2 (AUTHOR), Desbrosses, Y.3 (AUTHOR), Larosa, F.4 (AUTHOR), Chantepie, S.5 (AUTHOR), Larcher, M. V.6 (AUTHOR), Mear, J. B.7 (AUTHOR), Peterlin, P.8 (AUTHOR), Hunault-Berger, M.9 (AUTHOR), Hospital, M. A.10 (AUTHOR), Morel, V.11 (AUTHOR), Lucas, N.12 (AUTHOR), Vidal, V.13 (AUTHOR), Salanoubat, C.14 (AUTHOR), Michel, J.15 (AUTHOR), Mediavilla, C.16 (AUTHOR), Ojeda-Uribe, M.17 (AUTHOR), Alexis, M.18 (AUTHOR), Frayfer, J.19 (AUTHOR)
Source: Leukemia & Lymphoma. Jul2021, Vol. 62 Issue 7, p1756-1760. 5p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:10428194
DOI:10.1080/10428194.2021.1881505